Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 285

1.

Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant.

Yeh WS, Haller JA, Lanzetta P, Kuppermann BD, Wong TY, Mitchell P, Whitcup SM, Kowalski JW.

Ophthalmology. 2012 Jun;119(6):1190-8. doi: 10.1016/j.ophtha.2011.12.028. Epub 2012 Feb 22.

PMID:
22361318
[PubMed - indexed for MEDLINE]
2.

Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group.

Ophthalmology. 2010 Jun;117(6):1134-1146.e3. doi: 10.1016/j.ophtha.2010.03.032. Epub 2010 Apr 24.

PMID:
20417567
[PubMed - indexed for MEDLINE]
3.

Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.

Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group, Li J.

Ophthalmology. 2011 Dec;118(12):2453-60. doi: 10.1016/j.ophtha.2011.05.014. Epub 2011 Jul 20.

PMID:
21764136
[PubMed - indexed for MEDLINE]
4.

Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.

Mayer WJ, Remy M, Wolf A, Kook D, Kampik A, Ulbig M, Reznicek L, Haritoglou C.

Ophthalmologica. 2012;228(2):110-6. doi: 10.1159/000338732. Epub 2012 Jun 23.

PMID:
22739239
[PubMed - indexed for MEDLINE]
5.

Vascular changes in eyes treated with dexamethasone intravitreal implant for macular edema after retinal vein occlusion.

Sadda S, Danis RP, Pappuru RR, Keane PA, Jiao J, Li XY, Whitcup SM.

Ophthalmology. 2013 Jul;120(7):1423-31. doi: 10.1016/j.ophtha.2012.12.021. Epub 2013 Mar 15.

PMID:
23499064
[PubMed - indexed for MEDLINE]
6.

SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.

Coscas G, Coscas F, Zucchiatti I, Glacet-Bernard A, Soubrane G, Souïed E.

Eur J Ophthalmol. 2011 Sep-Oct;21(5):631-6. doi: 10.5301/EJO.2011.7428.

PMID:
21500185
[PubMed - indexed for MEDLINE]
7.

Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.

Bezatis A, Spital G, Höhn F, Maier M, Clemens CR, Wachtlin J, Lehmann F, Hattenbach LO, Feltgen N, Meyer CH.

Acta Ophthalmol. 2013 Aug;91(5):e340-7. doi: 10.1111/aos.12020. Epub 2013 May 3.

PMID:
23638803
[PubMed - indexed for MEDLINE]
8.

Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.

Jaissle GB, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Heimann H, Meyer CH; Retinal Vein Occlusion Study Group.

Graefes Arch Clin Exp Ophthalmol. 2011 Feb;249(2):183-92. doi: 10.1007/s00417-010-1470-2. Epub 2010 Aug 18.

PMID:
21337042
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study.

Epstein DL, Algvere PV, von Wendt G, Seregard S, Kvanta A.

Ophthalmology. 2012 Dec;119(12):2587-91. doi: 10.1016/j.ophtha.2012.06.037. Epub 2012 Aug 17.

PMID:
22902212
[PubMed - indexed for MEDLINE]
10.

SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.

Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Jumper JM, Figueroa M; SCORE Study Investigator Group.

Ophthalmology. 2009 Mar;116(3):504-12. doi: 10.1016/j.ophtha.2008.10.017. Epub 2009 Jan 22.

PMID:
19167078
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Prospective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month results.

Jain N, Stinnett SS, Jaffe GJ.

Ophthalmology. 2012 Jan;119(1):132-7. doi: 10.1016/j.ophtha.2011.06.019. Epub 2011 Sep 14.

PMID:
21924503
[PubMed - indexed for MEDLINE]
12.

Rebound effect after intravitreal dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion.

Parodi MB, Iacono P, De Benedetto U, Cascavilla M, Bandello F.

J Ocul Pharmacol Ther. 2012 Dec;28(6):566-8. doi: 10.1089/jop.2012.0016. Epub 2012 Jul 2.

PMID:
22746671
[PubMed - indexed for MEDLINE]
13.

Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.

Cakir M, Dogan M, Bayraktar Z, Bayraktar S, Acar N, Altan T, Kapran Z, Yilmaz OF.

Retina. 2008 Mar;28(3):465-72. doi: 10.1097/IAE.0b013e318154b9d1.

PMID:
18327140
[PubMed - indexed for MEDLINE]
14.

Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema.

Callanan DG, Gupta S, Boyer DS, Ciulla TA, Singer MA, Kuppermann BD, Liu CC, Li XY, Hollander DA, Schiffman RM, Whitcup SM; Ozurdex PLACID Study Group.

Ophthalmology. 2013 Sep;120(9):1843-51. doi: 10.1016/j.ophtha.2013.02.018. Epub 2013 May 22.

PMID:
23706947
[PubMed - indexed for MEDLINE]
15.

Combination therapy with dexamethasone intravitreal implant and macular grid laser in patients with branch retinal vein occlusion.

Pichi F, Specchia C, Vitale L, Lembo A, Morara M, Veronese C, Ciardella AP, Nucci P.

Am J Ophthalmol. 2014 Mar;157(3):607-15.e1. doi: 10.1016/j.ajo.2013.11.016. Epub 2013 Nov 27.

PMID:
24528934
[PubMed - indexed for MEDLINE]
16.

Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.

Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Hartnett ME, Cohen G; Standard Care versus COrticosteroid for REtinal Vein Occlusion Study Investigator Group.

Ophthalmology. 2011 Feb;118(2):345-52. doi: 10.1016/j.ophtha.2010.06.034.

PMID:
20926135
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Changes in macular function after ozurdex for retinal vein occlusion.

Querques G, Cascavilla ML, Cavallero E, Triolo G, Querques L, Lattanzio R, Cicinelli MV, Preziosa C, Borrelli E, Bandello F.

Optom Vis Sci. 2014 Jul;91(7):760-8. doi: 10.1097/OPX.0000000000000308.

PMID:
24927143
[PubMed - indexed for MEDLINE]
18.

Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study.

Epstein DL, Algvere PV, von Wendt G, Seregard S, Kvanta A.

Ophthalmology. 2012 Jun;119(6):1184-9. doi: 10.1016/j.ophtha.2012.01.022. Epub 2012 Mar 17.

PMID:
22424833
[PubMed - indexed for MEDLINE]
19.

Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.

Singer MA, Bell DJ, Woods P, Pollard J, Boord T, Herro A, Porbandarwalla S.

Retina. 2012 Jul;32(7):1289-94. doi: 10.1097/IAE.0b013e318242b838.

PMID:
22466480
[PubMed - indexed for MEDLINE]
20.

Improved visual outcome with early treatment in macular edema secondary to retinal vein occlusions: 6-month results of a Korean RVO study.

Yoon YH, Kim HK, Yoon HS, Kang SW, Kim JG, Park KH, Jo YJ, Lee JY, Lee DH; Korean RVO Study Group.

Jpn J Ophthalmol. 2014 Mar;58(2):146-54. doi: 10.1007/s10384-014-0305-9. Epub 2014 Jan 31.

PMID:
24477666
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk